B+
Bull case
25%
Probability
Target price
$21.00
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
NEO
NeoGenomicsCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The earnings release supports a constructive operating thesis: double-digit revenue growth, 26% NGS growth, improving adjusted EBITDA, higher average revenue per clinical test, and raised full-year guidance. The advanced-testing mix and pending reimbursement opportunities could support further growth.
Posture
Mixed
Lead driver
Sentiment
What changed
2 setup hits (3d) with net bullish as of 2026-09-09.
What can break
Clinical volume growth may not keep pace with pricing and mix benefits.
Momentum
90
Value
42
Sentiment
65
Setup hits (3d)
2 · Net Bullish
AI TargetsBase $18.50 · Bull $21.00 · Bear $13.25Analysis 2026-07-31; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-31 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $19.72
Why
Momentum90 · Δ7d -0.7
Value42 · Δ7d -0.0
Sentiment65 · Δ7d +5.4
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Confirming evidence
- • 2 setup hits (3d) with net bullish as of 2026-09-09.
- • Sentiment remains the lead driver in the composite, 7D delta +5.4.
Contradictions & invalidation
- • Clinical volume growth may not keep pace with pricing and mix benefits.
- • Convertible notes may increase dilution or create future capital-structure pressure.
- • Clinical volume increased only 2%, while reported GAAP net income was just $2 million and benefited from an $11 million debt-extinguishment gain.
Catalyst clock
2026-07-28
Q2 earnings showed durable growth and raised FY2026 guidance
Lead driver: Sentiment · See AI snapshot
Momentum
90
9% active weight
Current posture
7d trendFlat
Δ7d
-0.7
Δ21d
-4.2
Value
42
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.5
Sentiment
65
62% active weight
Current posture
7d trendImproving
Δ7d
+5.4
Δ21d
-11.6
Why this grade
Composite grade C. Momentum 89.6 / Value 41.9 / Sentiment 64.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-31. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$18.50
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$13.25
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$2.08B
Beta
1.57
Shares Out
128.48M
P/E (TTM) · Derived
-19.2
P/S (TTM)
2.20
P/FCF (TTM) · Derived
-277.19
Rev YoY
+11.2%
EPS YoY
-104.9%
Gross Margin
+41.7%
Op Margin
-7.0%
Net Debt
$249.84M
Current Ratio
3.60
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data